mTOR: a potential therapeutic target in osteoarthritis?

Area of Science:

• Biochemistry
• Cell Biology
• Rheumatology

Background:

• Osteoarthritis (OA) is a degenerative joint disease marked by cartilage loss, bone remodeling, and inflammation.
• Mammalian target of rapamycin (mTOR) regulates cell growth, proliferation, and protein synthesis.
• Emerging evidence links mTOR to cartilage development, homeostasis, and OA-related degeneration.

Purpose of the Study:

• To review the role of mTOR in cartilage development and homeostasis.
• To explore the potential of mTOR as a therapeutic target for osteoarthritis.

Main Methods:

• Literature review of studies investigating mTOR in cartilage biology and OA.
• Analysis of preclinical data on mTOR inhibition in OA mouse models.

Main Results:

• mTOR signaling is crucial for normal cartilage development and homeostasis.
• Pharmacological and genetic inhibition of mTOR has demonstrated efficacy in reducing OA severity in mouse models.
• These findings highlight mTOR's involvement in the pathological processes of OA.

Conclusions:

• mTOR plays a significant role in maintaining articular cartilage health.
• Targeting mTOR presents a promising therapeutic strategy for managing osteoarthritis.
• Further research is warranted to translate these findings into clinical applications.